Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effect of Mobile-Directly Observed Therapy (DOT) on Adherence to Hydroxyurea Treatment in Adult HbSS Patients at Muhimbili National Hospital (MNH) in Tanzania: a Pilot Study

NCT02844673 is registered in ClinicalTrials.gov with Muhimbili University of Health and Allied Sciences as lead sponsor.

NCT NCT02844673
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02844673 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effect of Mobile-Directly Observed Therapy (DOT) on Adherence to Hydroxyurea Treatment in Adult HbSS Patients at Muhimbili National Hospital (MNH) in Tanzania: a Pilot Study
Lead sponsor
Muhimbili University of Health and Allied Sciences
Phase
Phase 2
Overall status
Completed
Start date
April 28, 2017
Completion date
May 18, 2018
Enrollment
98 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

sickle cell anaemia